Activation of Adaptive and Innate Immune Cells via Localized IL2 Cytokine Factories Eradicates Mesothelioma TumorsAmanda Nash, Omid Veiseh, Samira Aghlara-Fotovat et al.|Clinical Cancer Research|2022Cited by 24
Abstract 4189: Evaluation of implantable cytokine factories in combination with checkpoint inhibitors for eradication of malignant pleural mesothelioma (MPM) tumors in mice with safe and predictable dosing in non-human primatesAmanda Nash, Omid Veiseh, Samira Aghlara-Fotovat et al.|Cancer Research|2022Cited by 1
Supplementary Figure from Activation of Adaptive and Innate Immune Cells via Localized IL2 Cytokine Factories Eradicates Mesothelioma TumorsAmanda Nash, Omid Veiseh, Samira Aghlara-Fotovat et al.|Unknown|2023Cited by 0
Supplementary Figure from Activation of Adaptive and Innate Immune Cells via Localized IL2 Cytokine Factories Eradicates Mesothelioma TumorsAmanda Nash, Omid Veiseh, Samira Aghlara-Fotovat et al.|Unknown|2023Cited by 0
Supplementary Figure from Activation of Adaptive and Innate Immune Cells via Localized IL2 Cytokine Factories Eradicates Mesothelioma TumorsAmanda Nash, Omid Veiseh, Samira Aghlara-Fotovat et al.|Unknown|2023Cited by 0